These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26985862)

  • 1. Vaccines for the prevention against the threat of MERS-CoV.
    Du L; Tai W; Zhou Y; Jiang S
    Expert Rev Vaccines; 2016 Sep; 15(9):1123-34. PubMed ID: 26985862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor-binding domain-based subunit vaccines against MERS-CoV.
    Zhang N; Tang J; Lu L; Jiang S; Du L
    Virus Res; 2015 Apr; 202():151-9. PubMed ID: 25445336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of Middle East respiratory syndrome coronavirus vaccines: a patent review.
    Choi J; Kim MG; Oh YK; Kim YB
    Expert Opin Ther Pat; 2017 Jun; 27(6):721-731. PubMed ID: 28121202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospects for a MERS-CoV spike vaccine.
    Zhou Y; Jiang S; Du L
    Expert Rev Vaccines; 2018 Aug; 17(8):677-686. PubMed ID: 30058403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
    Malczyk AH; Kupke A; Prüfer S; Scheuplein VA; Hutzler S; Kreuz D; Beissert T; Bauer S; Hubich-Rau S; Tondera C; Eldin HS; Schmidt J; Vergara-Alert J; Süzer Y; Seifried J; Hanschmann KM; Kalinke U; Herold S; Sahin U; Cichutek K; Waibler Z; Eickmann M; Becker S; Mühlebach MD
    J Virol; 2015 Nov; 89(22):11654-67. PubMed ID: 26355094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.
    Wang Y; Tai W; Yang J; Zhao G; Sun S; Tseng CK; Jiang S; Zhou Y; Du L; Gao J
    Hum Vaccin Immunother; 2017 Jul; 13(7):1615-1624. PubMed ID: 28277821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies and vaccines against Middle East respiratory syndrome coronavirus.
    Xu J; Jia W; Wang P; Zhang S; Shi X; Wang X; Zhang L
    Emerg Microbes Infect; 2019; 8(1):841-856. PubMed ID: 31169078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
    Jiaming L; Yanfeng Y; Yao D; Yawei H; Linlin B; Baoying H; Jinghua Y; Gao GF; Chuan Q; Wenjie T
    Vaccine; 2017 Jan; 35(1):10-18. PubMed ID: 27899228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope-Based Vaccine Target Screening against Highly Pathogenic MERS-CoV: An In Silico Approach Applied to Emerging Infectious Diseases.
    Shi J; Zhang J; Li S; Sun J; Teng Y; Wu M; Li J; Li Y; Hu N; Wang H; Hu Y
    PLoS One; 2015; 10(12):e0144475. PubMed ID: 26641892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development.
    Mubarak A; Alturaiki W; Hemida MG
    J Immunol Res; 2019; 2019():6491738. PubMed ID: 31089478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.
    Tang J; Zhang N; Tao X; Zhao G; Guo Y; Tseng CT; Jiang S; Du L; Zhou Y
    Hum Vaccin Immunother; 2015; 11(5):1244-50. PubMed ID: 25874632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus.
    Kim MH; Kim HJ; Chang J
    PLoS One; 2019; 14(7):e0220196. PubMed ID: 31329652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.
    Zhang N; Channappanavar R; Ma C; Wang L; Tang J; Garron T; Tao X; Tasneem S; Lu L; Tseng CT; Zhou Y; Perlman S; Jiang S; Du L
    Cell Mol Immunol; 2016 Mar; 13(2):180-90. PubMed ID: 25640653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MERS-CoV spike protein: Targets for vaccines and therapeutics.
    Wang Q; Wong G; Lu G; Yan J; Gao GF
    Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges.
    Cho H; Excler JL; Kim JH; Yoon IK
    Hum Vaccin Immunother; 2018 Feb; 14(2):304-313. PubMed ID: 29048984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MERS-CoV spike nanoparticles protect mice from MERS-CoV infection.
    Coleman CM; Venkataraman T; Liu YV; Glenn GM; Smith GE; Flyer DC; Frieman MB
    Vaccine; 2017 Mar; 35(12):1586-1589. PubMed ID: 28237499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice.
    Chi H; Zheng X; Wang X; Wang C; Wang H; Gai W; Perlman S; Yang S; Zhao J; Xia X
    Vaccine; 2017 Apr; 35(16):2069-2075. PubMed ID: 28314561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Highly Immunogenic, Protective, and Safe Adenovirus-Based Vaccine Expressing Middle East Respiratory Syndrome Coronavirus S1-CD40L Fusion Protein in a Transgenic Human Dipeptidyl Peptidase 4 Mouse Model.
    Hashem AM; Algaissi A; Agrawal AS; Al-Amri SS; Alhabbab RY; Sohrab SS; S Almasoud A; Alharbi NK; Peng BH; Russell M; Li X; Tseng CK
    J Infect Dis; 2019 Oct; 220(10):1558-1567. PubMed ID: 30911758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced protection in mice induced by immunization with inactivated whole viruses compare to spike protein of middle east respiratory syndrome coronavirus.
    Deng Y; Lan J; Bao L; Huang B; Ye F; Chen Y; Yao Y; Wang W; Qin C; Tan W
    Emerg Microbes Infect; 2018 Apr; 7(1):60. PubMed ID: 29618723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein.
    Al-Amri SS; Abbas AT; Siddiq LA; Alghamdi A; Sanki MA; Al-Muhanna MK; Alhabbab RY; Azhar EI; Li X; Hashem AM
    Sci Rep; 2017 Mar; 7():44875. PubMed ID: 28332568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.